FDA — authorised 7 February 2007
- Application: NDA021887
- Marketing authorisation holder: HALEON US HOLDINGS
- Local brand name: ALLI
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Combination of treatments in United States
FDA authorised Combination of treatments on 7 February 2007
Marketing authorisation
Frequently asked questions
Is Combination of treatments approved in United States?
Yes. FDA authorised it on 7 February 2007.
Who is the marketing authorisation holder for Combination of treatments in United States?
HALEON US HOLDINGS holds the US marketing authorisation.